Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Treatment of Hepatitis C Virus Infection in Real Life

Treatment of Hepatitis C Virus Infection in Real Life Treatment of Hepatitis C Virus Genotype 1 by Stage of Liver Fibrosis Original Investigation Research 56. Cardoso AC, Moucari R, Figueiredo-Mendes C, 61. Ng V, Saab S. Effects of a sustained virologic 66. Brennan TA, Lotvin A, Shrank W. Analysis of et al. Impact of peginterferon and ribavirin therapy response on outcomes of patients with chronic “real world” Sovaldi (sofosbuvir) use and on hepatocellular carcinoma: incidence and survival hepatitis C. Clin Gastroenterol Hepatol. 2011;9(11): discontinuation rates. CVS Health. https://www in hepatitis C patients with advanced fibrosis. 923-930. .cvshealth.com/sites/default/files/styles J Hepatol. 2010;52(5):652-657. /SovaldiUseAndDiscontinuation_ResearchArticle 62. Reuters. Anthem selects Gilead as primary _PDF.pdf. September 2014. Accessed October 1, 2014. 57. McCombs J, Matsuda T, Tonnu-Mihara I, et al. supplier of hepatitis C drugs. http://www.reuters The risk of long-term morbidity and mortality in .com/article/2015/01/08/anthem-gilead-hepatitis 67. Belperio PS. Treating hepatitis C in Veterans patients with chronic hepatitis C: results from an -idUSL1N0UN2IV20150108. Published January 8, Affairs (VA): early experience with sofosbuvir-based analysis of data from a Department of Veterans 2105. Accessed April 15, 2015. regimens. Palo Alto, CA: VA Office of Public Affairs clinical registry. JAMA Intern Med. 2014;174 Health/Population Health and VA Pharmacy Benefits 63. Express scripts and AbbVie make hepatitis C (2):204-212. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA Internal Medicine American Medical Association

Treatment of Hepatitis C Virus Infection in Real Life

JAMA Internal Medicine , Volume 176 (1) – Jan 1, 2016

Loading next page...
 
/lp/american-medical-association/treatment-of-hepatitis-c-virus-infection-in-real-life-O1jKF3o4gN

References (6)

Publisher
American Medical Association
Copyright
Copyright 2016 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
ISSN
2168-6106
eISSN
2168-6114
DOI
10.1001/jamainternmed.2015.6659
pmid
26595164
Publisher site
See Article on Publisher Site

Abstract

Treatment of Hepatitis C Virus Genotype 1 by Stage of Liver Fibrosis Original Investigation Research 56. Cardoso AC, Moucari R, Figueiredo-Mendes C, 61. Ng V, Saab S. Effects of a sustained virologic 66. Brennan TA, Lotvin A, Shrank W. Analysis of et al. Impact of peginterferon and ribavirin therapy response on outcomes of patients with chronic “real world” Sovaldi (sofosbuvir) use and on hepatocellular carcinoma: incidence and survival hepatitis C. Clin Gastroenterol Hepatol. 2011;9(11): discontinuation rates. CVS Health. https://www in hepatitis C patients with advanced fibrosis. 923-930. .cvshealth.com/sites/default/files/styles J Hepatol. 2010;52(5):652-657. /SovaldiUseAndDiscontinuation_ResearchArticle 62. Reuters. Anthem selects Gilead as primary _PDF.pdf. September 2014. Accessed October 1, 2014. 57. McCombs J, Matsuda T, Tonnu-Mihara I, et al. supplier of hepatitis C drugs. http://www.reuters The risk of long-term morbidity and mortality in .com/article/2015/01/08/anthem-gilead-hepatitis 67. Belperio PS. Treating hepatitis C in Veterans patients with chronic hepatitis C: results from an -idUSL1N0UN2IV20150108. Published January 8, Affairs (VA): early experience with sofosbuvir-based analysis of data from a Department of Veterans 2105. Accessed April 15, 2015. regimens. Palo Alto, CA: VA Office of Public Affairs clinical registry. JAMA Intern Med. 2014;174 Health/Population Health and VA Pharmacy Benefits 63. Express scripts and AbbVie make hepatitis C (2):204-212.

Journal

JAMA Internal MedicineAmerican Medical Association

Published: Jan 1, 2016

There are no references for this article.